Free shipping on orders of €99 or more

BPC-157 with Arginine Salt

BPC-157 with Arginine Salt

Price range: €37,49 through €449,63
Accepted payment methods
Free shipping on orders of €99 or more. USPS Regular Shipping: €11,95 · FedEx 2 Days Delivery: €28,99 · FedEx Overnight Delivery: €40,99 Shipping details

BPC-157 is a synthetic 15-amino-acid pentadecapeptide derived from the gastric mucosal protein BPC.

Price range: €37,49 through €449,63

The image represents one available format. Strength and pack size are those selected above.

Accepted payment methods
Free shipping on orders of €99 or more. USPS Regular Shipping: €11,95 · FedEx 2 Days Delivery: €28,99 · FedEx Overnight Delivery: €40,99 Shipping details

-25% on everything – until October 31
25% off regular prices, replacing other product sales. Only the crypto payment discount can be combined.

Overview

BPC-157 is a synthetic 15-amino-acid pentadecapeptide derived from the gastric mucosal protein BPC. In vitro studies document interactions with VEGFR2, EGFR, and FAK phosphorylation cascades, with modulation of pro-angiogenic signalling networks. Preclinical in vivo models have examined its effects on nitric oxide synthase activity, extracellular matrix protein expression, and actin cytoskeletal dynamics in connective tissue contexts.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Molecular data on PubChem

BPC-157 with Arginine Salt5mg 1 vial | 5mg 10 vials | 10mg 1 vial | 10mg 10 vials

Properties

Chemical Formula C68H112N20O24
Synonyms Body Protection Compound-157, Bepecin, PL 14736
Molar Mass 1,419.5 g/mol
CAS Number 137525-51-0
PubChem CID 175763564
Available formats 5mg 1 vial · 5mg 10 vials · 10mg 1 vial · 10mg 10 vials
Shelf Life 36 months

Research

BPC-157 is a synthetic pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) identified as a partial sequence of the gastric cytoprotective protein BPC. In cell-based assays, BPC-157 potentiates VEGFR2 phosphorylation and downstream ERK1/2 activation, implicating modulation of pro-angiogenic signalling axes. Additional in vitro data indicate upregulation of focal adhesion kinase (FAK) activity and actin cytoskeletal reorganisation, consistent with observed effects on cell migration in scratch-wound models. In preclinical in vivo studies, administration is associated with eNOS expression upregulation, collagen fibril remodelling, and fibroblast proliferation responses — processes of interest across connective tissue biology, angiogenesis research, and extracellular matrix remodelling models. The peptide exhibits stability across physiological pH and is supplied lyophilised for laboratory reconstitution. Independently third-party HPLC-tested; COA available per batch.

Lab Results

Results refer to the tested sample. Check the batch and date in the report.

BPC-157 with Arginine Salt 10mg (HPLC) 2607-ED-BP
September 13, 2026
BPC-157 with Arginine Salt 10mg (HPLC) 2608-ED-BP
September 13, 2026
BPC-157 with Arginine Salt (HPLC) 2606-ED-BP
July 22, 2026
BPC-157 with Arginine Salt (HPLC) J26AYBPC
July 21, 2026
BPC-157 with Arginine Salt 10mg (HPLC) 2605-ED-BP
July 21, 2026
BPC-157 with Arginine Salt (HPLC) J26HGBPC
July 21, 2026
BPC-157 with Arginine Salt 5mg (HPLC) ED9319
June 25, 2026
BPC-157 (GC-MS/LC-MS Contamination Screening) 5748
June 17, 2026
BPC-157 (Heavy Metal) 5748
June 16, 2026

FAQ

Why does BPC-157 demonstrate greater stability than many peptide-based research compounds?

BPC-157 contains multiple proline-rich motifs that are believed to contribute to resistance against enzymatic degradation under a range of experimental conditions. This structural characteristic distinguishes it from many peptide-based research compounds and has contributed to interest in its biochemical stability, peptide persistence, and signaling activity in mechanistic investigations.

What is the relationship between BPC-157 and VEGFR2/FAK signaling pathways?

Experimental investigations have reported enhanced VEGFR2 phosphorylation together with increased focal adhesion kinase (FAK) activity and downstream ERK1/2 signaling. These observations have positioned BPC-157 as a useful research tool for studying angiogenic signaling networks, cellular migration processes, cytoskeletal organization, and extracellular matrix-associated pathway regulation.

How does BPC-157 differ from TB-500 in mechanistic research?

BPC-157 and TB-500 are frequently compared because they influence distinct signaling networks. Research involving BPC-157 has focused primarily on VEGFR2, FAK, ERK1/2, eNOS, and extracellular matrix-associated pathways, whereas TB-500 investigations emphasize actin dynamics, cytoskeletal organization, cell migration, and tissue remodeling mechanisms.

Their differing mechanistic profiles make them valuable tools for comparative studies of peptide-mediated signaling and cellular regulatory processes.